4 Podcast Episodes
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
Patients at a high risk of bleeding (HBR) are a common subgroup of those receiving percutaneous coronary intervention (P... Read more
31 May 2022
•
1min
Effect of Ticagrelor Monotherapy vs Ticagrelor with Aspirin on Major Bleeding and Cardiovascular Events in Patients with Acute Coronary Syndrome: The TICO Randomized Clinical Trial
Effect of Ticagrelor Monotherapy vs Ticagrelor with Aspirin on Major Bleeding and Cardiovascular Events in Patients with Acute Coronary Syndrome: The TICO Randomized Clinical Trial
In the TICO randomized clinical trial, stopping aspirin was tested as a bleeding reduction method after short-term dual ... Read more
27 May 2022
•
2mins
Episode 92: TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin
Episode 92: TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin
C. Michael Gibson reviews the randomized TWILIGHT trial results with Roxana Mehran.
1 Apr 2020
•
5mins
Ischemic Efficacy and Bleeding Safety of Long-term Ticagrelor Monotherapy in Patients with Multivessel PCI
Ischemic Efficacy and Bleeding Safety of Long-term Ticagrelor Monotherapy in Patients with Multivessel PCI
Commentary by Dr. Valentin Fuster
15 Oct 2019
•
11mins